Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0082 Transporter Info | ||||
Gene Name | SLC12A1 | ||||
Transporter Name | Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Hepatocellular carcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
5'UTR (cg10829727) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.60E+00 | Statistic Test | p-value:6.02E-17; Z-score:2.91E+00 | ||
Methylation in Case |
4.93E-01 (Median) | Methylation in Control | 3.07E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg14583675) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:9.67E-14; Z-score:2.18E+00 | ||
Methylation in Case |
6.71E-01 (Median) | Methylation in Control | 5.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg20388916) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.42E+00 | Statistic Test | p-value:6.55E-11; Z-score:-3.28E+00 | ||
Methylation in Case |
4.47E-01 (Median) | Methylation in Control | 6.37E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:1.04E-08; Z-score:-2.79E+00 | ||
Methylation in Case |
5.77E-01 (Median) | Methylation in Control | 7.45E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg14857792) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.36E+00 | Statistic Test | p-value:1.99E-08; Z-score:-3.11E+00 | ||
Methylation in Case |
4.28E-01 (Median) | Methylation in Control | 5.82E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC12A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:5.97E-05; Z-score:-1.22E+00 | ||
Methylation in Case |
6.82E-01 (Median) | Methylation in Control | 7.46E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC12A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg23530596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:4.13E-04; Z-score:-2.21E+00 | ||
Methylation in Case |
3.08E-01 (Median) | Methylation in Control | 4.13E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg26317549) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.29E+00 | Statistic Test | p-value:2.95E-12; Z-score:-1.44E+01 | ||
Methylation in Case |
3.20E-01 (Median) | Methylation in Control | 7.31E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg07915221) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:9.45E-06; Z-score:-2.03E+01 | ||
Methylation in Case |
7.38E-01 (Median) | Methylation in Control | 9.31E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg21384789) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:4.28E-04; Z-score:-3.57E+00 | ||
Methylation in Case |
8.33E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14167964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.57E+00 | Statistic Test | p-value:6.03E-09; Z-score:-8.44E+00 | ||
Methylation in Case |
3.29E-01 (Median) | Methylation in Control | 8.45E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14930674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.45E+00 | Statistic Test | p-value:6.81E-07; Z-score:-6.57E+01 | ||
Methylation in Case |
5.30E-01 (Median) | Methylation in Control | 7.71E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg23530596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.90E+00 | Statistic Test | p-value:1.30E-06; Z-score:-8.61E+00 | ||
Methylation in Case |
2.37E-01 (Median) | Methylation in Control | 4.49E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.57E+00 | Statistic Test | p-value:1.57E-06; Z-score:-1.21E+01 | ||
Methylation in Case |
5.29E-01 (Median) | Methylation in Control | 8.34E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14857792) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.83E+00 | Statistic Test | p-value:4.00E-06; Z-score:-7.06E+00 | ||
Methylation in Case |
3.73E-01 (Median) | Methylation in Control | 6.85E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.36E+00 | Statistic Test | p-value:6.16E-06; Z-score:-1.60E+01 | ||
Methylation in Case |
6.48E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC12A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg13944105) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.40E+00 | Statistic Test | p-value:6.70E-04; Z-score:-7.55E+00 | ||
Methylation in Case |
3.66E-01 (Median) | Methylation in Control | 5.12E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg07915221) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:5.71E-06; Z-score:-1.26E+00 | ||
Methylation in Case |
8.87E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg26317549) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.21E+00 | Statistic Test | p-value:1.90E-03; Z-score:-1.15E+00 | ||
Methylation in Case |
5.66E-01 (Median) | Methylation in Control | 6.84E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:9.85E-14; Z-score:-2.54E+00 | ||
Methylation in Case |
7.44E-01 (Median) | Methylation in Control | 8.50E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg23530596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.36E+00 | Statistic Test | p-value:9.25E-09; Z-score:1.74E+00 | ||
Methylation in Case |
3.58E-01 (Median) | Methylation in Control | 2.64E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:9.24E-08; Z-score:-1.37E+00 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 8.59E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC12A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg14167964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:1.87E-07; Z-score:-1.26E+00 | ||
Methylation in Case |
7.23E-01 (Median) | Methylation in Control | 7.78E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC12A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg14930674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:6.06E-03; Z-score:-3.35E-01 | ||
Methylation in Case |
7.72E-01 (Median) | Methylation in Control | 7.80E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC12A1 in breast cancer | [ 3 ] | |||
Location |
Body (cg14857792) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:4.21E-02; Z-score:-5.35E-01 | ||
Methylation in Case |
6.36E-01 (Median) | Methylation in Control | 6.89E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg26317549) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.30E+00 | Statistic Test | p-value:9.68E-15; Z-score:-6.11E+00 | ||
Methylation in Case |
6.57E-01 (Median) | Methylation in Control | 8.57E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg07915221) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:2.90E-02; Z-score:3.47E-02 | ||
Methylation in Case |
9.43E-01 (Median) | Methylation in Control | 9.42E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg23530596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.40E+00 | Statistic Test | p-value:1.07E-15; Z-score:-4.25E+00 | ||
Methylation in Case |
5.08E-01 (Median) | Methylation in Control | 7.14E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg14857792) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.27E+00 | Statistic Test | p-value:4.94E-12; Z-score:-4.99E+00 | ||
Methylation in Case |
6.55E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:4.44E-09; Z-score:-2.80E+00 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 9.02E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:2.68E-06; Z-score:-3.16E+00 | ||
Methylation in Case |
8.68E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg14930674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:1.72E-05; Z-score:-2.28E+00 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.93E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg13944105) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:6.20E-05; Z-score:-1.12E+00 | ||
Methylation in Case |
6.65E-01 (Median) | Methylation in Control | 7.99E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC12A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg14167964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.66E-03; Z-score:-5.46E-01 | ||
Methylation in Case |
8.67E-01 (Median) | Methylation in Control | 8.97E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in HIV infection | [ 5 ] | |||
Location |
TSS1500 (cg26317549) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:4.50E-05; Z-score:-1.43E+00 | ||
Methylation in Case |
7.40E-01 (Median) | Methylation in Control | 7.92E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in HIV infection | [ 5 ] | |||
Location |
Body (cg23530596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:4.84E-07; Z-score:-2.03E+00 | ||
Methylation in Case |
6.73E-01 (Median) | Methylation in Control | 7.64E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in HIV infection | [ 5 ] | |||
Location |
Body (cg13944105) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:5.50E-06; Z-score:-2.28E+00 | ||
Methylation in Case |
7.80E-01 (Median) | Methylation in Control | 8.59E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in HIV infection | [ 5 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:3.29E-04; Z-score:-1.22E+00 | ||
Methylation in Case |
8.40E-01 (Median) | Methylation in Control | 8.92E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in HIV infection | [ 5 ] | |||
Location |
Body (cg14857792) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:1.46E-03; Z-score:-1.22E+00 | ||
Methylation in Case |
7.57E-01 (Median) | Methylation in Control | 8.17E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC12A1 in HIV infection | [ 5 ] | |||
Location |
Body (cg14167964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.02E-02; Z-score:-6.81E-01 | ||
Methylation in Case |
9.21E-01 (Median) | Methylation in Control | 9.34E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC12A1 in HIV infection | [ 5 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.09E-02; Z-score:-4.83E-01 | ||
Methylation in Case |
8.60E-01 (Median) | Methylation in Control | 8.80E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg20392607) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:6.84E+00 | Statistic Test | p-value:3.19E-30; Z-score:4.90E+00 | ||
Methylation in Case |
3.63E-01 (Median) | Methylation in Control | 5.30E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg12367786) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.21E+00 | Statistic Test | p-value:1.80E-04; Z-score:-1.08E+00 | ||
Methylation in Case |
3.98E-01 (Median) | Methylation in Control | 4.82E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg16667710) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.94E-02; Z-score:-3.07E-01 | ||
Methylation in Case |
8.86E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg10841552) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.77E+00 | Statistic Test | p-value:1.35E-21; Z-score:3.72E+00 | ||
Methylation in Case |
4.33E-01 (Median) | Methylation in Control | 2.44E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg04408162) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:4.24E-10; Z-score:-2.14E+00 | ||
Methylation in Case |
2.79E-01 (Median) | Methylation in Control | 3.49E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC12A1 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg25196715) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:1.08E-03; Z-score:9.34E-01 | ||
Methylation in Case |
8.92E-01 (Median) | Methylation in Control | 8.67E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in panic disorder | [ 7 ] | |||
Location |
TSS1500 (cg26317549) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:6.05E-03; Z-score:4.56E-01 | ||
Methylation in Case |
1.94E+00 (Median) | Methylation in Control | 1.79E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in panic disorder | [ 7 ] | |||
Location |
TSS1500 (cg07915221) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.38E+00 | Statistic Test | p-value:2.57E-02; Z-score:5.07E-01 | ||
Methylation in Case |
7.59E-01 (Median) | Methylation in Control | 5.50E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in panic disorder | [ 7 ] | |||
Location |
Body (cg14167964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.70E+00 | Statistic Test | p-value:1.16E-04; Z-score:-7.15E-01 | ||
Methylation in Case |
1.95E-01 (Median) | Methylation in Control | 5.27E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in panic disorder | [ 7 ] | |||
Location |
Body (cg13944105) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:5.36E-03; Z-score:5.99E-01 | ||
Methylation in Case |
1.67E+00 (Median) | Methylation in Control | 1.45E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in panic disorder | [ 7 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.31E+00 | Statistic Test | p-value:9.73E-03; Z-score:5.28E-01 | ||
Methylation in Case |
9.10E-01 (Median) | Methylation in Control | 6.97E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in papillary thyroid cancer | [ 8 ] | |||
Location |
TSS1500 (cg26317549) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:8.12E-03; Z-score:-1.26E-01 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 7.76E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in papillary thyroid cancer | [ 8 ] | |||
Location |
TSS1500 (cg07915221) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:4.06E-02; Z-score:-4.70E-01 | ||
Methylation in Case |
9.40E-01 (Median) | Methylation in Control | 9.46E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.90E-03; Z-score:-6.38E-01 | ||
Methylation in Case |
9.13E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg23530596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:6.13E-03; Z-score:-9.49E-01 | ||
Methylation in Case |
6.16E-01 (Median) | Methylation in Control | 6.65E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:7.32E-03; Z-score:-4.36E-01 | ||
Methylation in Case |
8.63E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in prostate cancer | [ 9 ] | |||
Location |
TSS1500 (cg22294577) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:1.10E-02; Z-score:5.09E+00 | ||
Methylation in Case |
9.10E-01 (Median) | Methylation in Control | 8.49E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in prostate cancer | [ 9 ] | |||
Location |
TSS1500 (cg02428538) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:3.98E-02; Z-score:1.48E+00 | ||
Methylation in Case |
9.50E-01 (Median) | Methylation in Control | 9.22E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
TSS1500 (cg26317549) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:8.95E-03; Z-score:-1.50E-01 | ||
Methylation in Case |
7.92E-01 (Median) | Methylation in Control | 8.02E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg14930674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.31E-03; Z-score:-2.27E-01 | ||
Methylation in Case |
8.89E-01 (Median) | Methylation in Control | 8.95E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg14857792) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:4.32E-03; Z-score:-3.11E-01 | ||
Methylation in Case |
7.84E-01 (Median) | Methylation in Control | 8.04E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.97E-02; Z-score:-2.20E-01 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 8.45E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC12A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg13944105) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.19E-02; Z-score:-1.27E-01 | ||
Methylation in Case |
8.14E-01 (Median) | Methylation in Control | 8.25E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC12A1 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg23530596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:3.74E-02; Z-score:4.30E-03 | ||
Methylation in Case |
7.27E-01 (Median) | Methylation in Control | 7.26E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.28E+00 | Statistic Test | p-value:1.66E-02; Z-score:-3.16E-01 | ||
Methylation in Case |
3.45E-02 (Median) | Methylation in Control | 7.86E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg13944105) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.01E-02; Z-score:4.34E-01 | ||
Methylation in Case |
8.85E-01 (Median) | Methylation in Control | 8.53E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg14167964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:4.28E-02; Z-score:-6.74E-01 | ||
Methylation in Case |
1.51E-01 (Median) | Methylation in Control | 1.94E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC12A1 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.36E-02; Z-score:2.81E-01 | ||
Methylation in Case |
7.66E-01 (Median) | Methylation in Control | 7.36E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC12A1 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg14229516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:6.27E-03; Z-score:-1.78E+00 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC12A1 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg10616694) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:1.57E-02; Z-score:-1.67E+00 | ||
Methylation in Case |
7.60E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC12A1 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg14930674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:3.56E-02; Z-score:-1.20E+00 | ||
Methylation in Case |
7.94E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Renal cell carcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Higher expression of miR-21 in clear cell renal cell carcinoma (compare with normal kidney tissue) | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Chromatin immunoprecipitation | ||
Related Molecular Changes | Down regulation ofSLC12A1 | Experiment Method | RT-qPCR | ||
miRNA Stemloop ID |
miR-21 | miRNA Mature ID | miR-21-5p | ||
miRNA Sequence |
UAGCUUAUCAGACUGAUGUUGA | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
miR-21 was up-regulated in clear cell renal cell carcinoma and regulated SLC12A1 expression via binding to the SLC12A1 mRNA. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.